	債務の支払利息		日付
AbbVie	USD 645M	69M	2026-03
Amgen	USD 95.64B	94.98B	2026-06
Anika Therapeutics	183.47M	4.09M	2026-06
Arrowhead Research	USD 24.56M	716K	2026-06
AstraZeneca	USD 340M	144M	2026-06
BioCryst Pharmaceuticals	USD 21.71M	7.58M	2026-06
Biogen	USD 72.6M	12.6M	2025-06
Bristol-Myers Squibb	USD 407M	4M	2026-06
Enanta Pharmaceuticals	USD 1.96M	620K	2024-12
Gilead Sciences	USD 247M	7M	2026-06
GlaxoSmithKline	GBP 121M	46M	2026-06
Halozyme Therapeutics	USD 5.59M	80K	2026-06
Heron Therapeutics	USD 600K	100K	2024-12
Immunic	197K	222K	2025-12
Incyte	USD 582K	13K	2026-06
Insmed	USD 18.84M	1.24M	2026-06
Ionis Pharmaceuticals	USD 18M	1000K	2026-06
J&J	USD 43M	25M	2026-03
Karyopharm Therapeutics	USD 12.55M	66K	2026-03
Ligand Pharmaceuticals	USD 1.78M	875K	2025-12
Merck	USD 525M	46M	2026-06
Neurocrine Biosciences	USD 1.1M	0	2024-03
Novartis	USD 462M	119M	2026-06
Novavax	USD 5.82M	342K	2025-12
Pfizer	USD 667M	4M	2026-06
PTC Therapeutics	USD 3.25B	381.37M	2026-06
Roche Holding	CHF 304M	7.5M	2025-06
Sarepta Therapeutics	USD 21.51M	205K	2026-06
Vertex Pharmaceuticals	USD 3.3M	0	2025-12